MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity

被引:3
|
作者
Stindt, Maren H. [1 ]
Carter, Stephanie [1 ]
Vigneron, Arnaud M. [1 ]
Ryan, Kevin M. [1 ]
Vousden, Karen H. [1 ]
机构
[1] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland
关键词
p53; SUMO-2/3; SUMOylation; MDM2; ARF; L11; TUMOR-SUPPRESSOR; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; LIGASE ACTIVITY; NUCLEAR EXPORT; E3; LIGASE; PROTEIN; SUMOYLATION; DOMAIN; UBIQUITINATION;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The tumor suppressor p53 is extensively regulated by post-translational modification, including modification by the small ubiquitin-related modifier SUMO. We show here that MDM2, previously shown to promote ubiquitin, Nedd8 and SUMO-1 modification of p53, can also enhance conjugation of endogenous SUMO-2/3 to p53. SUMOylation activity requires p53-MDM2 binding but does not depend on an intact RING finger. Both ARF and L11 can promote SUMO-2/3 conjugation of p53. However, unlike the previously described SUMO-1 conjugation of p53 by an MDM2-ARF complex, this activity does not depend on the ability of MDM2 to relocalize to the nucleolus. Interestingly, the SUMO consensus is not conserved in mouse p53, which is therefore not modified by SUMO-2/3. Finally, we show that conjugation of SUMO-2/3 to p53 correlates with a reduction of both activation and repression of a subset of p53 target genes.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] RETRACTED: SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53 (Retracted Article)
    Buschmann, T
    Fuchs, SY
    Lee, CG
    Pan, ZQ
    Ronai, Z
    [J]. CELL, 2000, 101 (07) : 753 - 762
  • [32] MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output
    Chen, Lihong
    Li, Zhenyu
    Zwolinska, Aleksandra K.
    Smith, Matthew A.
    Cross, Brittany
    Koomen, John
    Yuan, Zhi-Min
    Jenuwein, Thomas
    Marine, Jean-Christophe
    Wright, Kenneth L.
    Chen, Jiandong
    [J]. EMBO JOURNAL, 2010, 29 (15): : 2538 - 2552
  • [33] HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function
    Di Stefano, V
    Blandino, G
    Sacchi, A
    Soddu, S
    D'Orazi, G
    [J]. ONCOGENE, 2004, 23 (30) : 5185 - 5192
  • [34] Regulation of p53 stability by Mdm2
    Michael H. G. Kubbutat
    Stephen N. Jones
    Karen H. Vousden
    [J]. Nature, 1997, 387 : 299 - 303
  • [35] mdm2/p53与肿瘤
    金永丽
    王靖华
    陈龙邦
    [J]. 临床肿瘤学杂志, 2007, (06) : 469 - 471
  • [36] p53和mdm2基因
    沈行良
    翁启芳
    [J]. 中国热带医学, 2007, (01) : 103 - 105
  • [37] Mdm2: p53's lifesaver?
    Shmueli, Ayelet
    Oren, Moshe
    [J]. MOLECULAR CELL, 2007, 25 (06) : 794 - 796
  • [38] HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function
    Valeria Di Stefano
    Giovanni Blandino
    Ada Sacchi
    Silvia Soddu
    Gabriella D'Orazi
    [J]. Oncogene, 2004, 23 : 5185 - 5192
  • [39] Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53
    Xirodimas, DP
    Stephen, CW
    Lane, DP
    [J]. EXPERIMENTAL CELL RESEARCH, 2001, 270 (01) : 66 - 77
  • [40] Parthenolide promotes the ubiquitination of MDM2 and activates p53 cellular functions
    Gopal, Y. N. Vashisht
    Chanchorn, Ekkavvit
    Van Dyke, Michael W.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2009, 8 (03) : 552 - 562